Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Ofatumumab for Multiple Sclerosis
Recruiting2 awardsPhase 3
Las Vegas, Nevada
This trial will test how well ofatumumab works in people with relapsing-remitting multiple sclerosis who are switching from another approved MS drug.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.